---
title: "The 'Standout Performance' That Could Save Thermo Fisher, Danaher And Others"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293644423.md"
description: "On Thursday, Thermo Fisher stock spearheaded a recovery in the medtech sector, alleviating concerns of prolonged stagnation in medical research and tools. This standout performance signaled hope for Thermo Fisher, Danaher, and similar companies amidst market uncertainty."
datetime: "2026-07-23T15:51:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293644423.md)
  - [en](https://longbridge.com/en/news/293644423.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293644423.md)
generator: "portal-rs"
---

# The 'Standout Performance' That Could Save Thermo Fisher, Danaher And Others

On Thursday, Thermo Fisher stock spearheaded a recovery in the medtech sector, alleviating concerns of prolonged stagnation in medical research and tools. This standout performance signaled hope for Thermo Fisher, Danaher, and similar companies amidst market uncertainty.

### Related Stocks

- [TMO.US](https://longbridge.com/en/quote/TMO.US.md)
- [DHR.US](https://longbridge.com/en/quote/DHR.US.md)

## Related News & Research

- [48,493 Shares in Thermo Fisher Scientific Inc. $TMO Purchased by United Capital Financial Advisors LLC](https://longbridge.com/en/news/297307715.md)
- [Northstar Asset Management Inc. Lowers Stock Position in Danaher Corporation $DHR](https://longbridge.com/en/news/297400881.md)
- [09:41 ETMammotome Accelerates Production as Public Health Response to Nationwide Breast Biopsy Needle Shortage](https://longbridge.com/en/news/297924402.md)
- [Simplify Asset Management Inc. Buys 5,670 Shares of Thermo Fisher Scientific Inc. $TMO](https://longbridge.com/en/news/296019005.md)
- [CLSA: Global Pharma Supply Chain Enters Decade-long Restructuring; Prefers Platform Leaders Including Thermo Fisher Scientific Inc , WUXI APPTEC](https://longbridge.com/en/news/297863665.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**